InsiderTrades

Form 4/A for URGN UroGen Pharma Ltd.

Accepted 2021-07-12 00:00:00 ET · period of report 2020-02-03 · accession 0001209191-21-046340 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMA 2021-07-12 2020-02-03+ URGN Barrett Elizabeth A. CEO M - OptEx — +35.2K 131.0K +37% —
DMA 2021-07-12 2020-02-03+ URGN Barrett Elizabeth A. CEO M - OptEx $0.00 -35.2K 176.1K -17% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares 2020-05-03 M A 8,808 — 157,465 D — — (F1) On May 14, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 35,229 shares vested on May 3, 2020. In fact, the shares vested monthly from February 3, 2020. (F2) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
2 Common Ordinary Shares 2020-04-03 M A 8,807 — 148,657 D — — (F1) On May 14, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 35,229 shares vested on May 3, 2020. In fact, the shares vested monthly from February 3, 2020. (F2) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
3 Common Ordinary Shares 2020-03-03 M A 8,807 — 139,850 D — — (F1) On May 14, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 35,229 shares vested on May 3, 2020. In fact, the shares vested monthly from February 3, 2020. (F2) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
4 Common Ordinary Shares 2020-02-03 M A 8,807 — 131,043 D — — (F1) On May 14, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 35,229 shares vested on May 3, 2020. In fact, the shares vested monthly from February 3, 2020. (F2) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
5 Derivative Restricted Stock Units 2020-02-03 M D 8,807 $0.00 202,570 D — · — to — 8,807 Ordinary Shares (F1) On May 14, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 35,229 shares vested on May 3, 2020. In fact, the shares vested monthly from February 3, 2020. (F2) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. (F3) On January 3, 2019, the reporting person was granted restricted stock units ("RSUs") representing 317,065 ordinary shares. 1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years.
6 Derivative Restricted Stock Units 2020-03-03 M D 8,807 $0.00 193,763 D — · — to — 8,807 Ordinary Shares (F1) On May 14, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 35,229 shares vested on May 3, 2020. In fact, the shares vested monthly from February 3, 2020. (F2) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. (F3) On January 3, 2019, the reporting person was granted restricted stock units ("RSUs") representing 317,065 ordinary shares. 1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years.
7 Derivative Restricted Stock Units 2020-04-03 M D 8,807 $0.00 198,956 D — · — to — 8,807 Ordinary Shares (F1) On May 14, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 35,229 shares vested on May 3, 2020. In fact, the shares vested monthly from February 3, 2020. (F2) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. (F3) On January 3, 2019, the reporting person was granted restricted stock units ("RSUs") representing 317,065 ordinary shares. 1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years.
8 Derivative Restricted Stock Units 2020-05-03 M D 8,808 $0.00 176,148 D — · — to — 8,808 Ordinary Shares (F1) On May 14, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 35,229 shares vested on May 3, 2020. In fact, the shares vested monthly from February 3, 2020. (F2) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. (F3) On January 3, 2019, the reporting person was granted restricted stock units ("RSUs") representing 317,065 ordinary shares. 1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years.